Details of the Drug Combination

General Information of Drug Combination (ID: DCTBTZV)

Drug Combination Name
GYKI-52466 Acarbose
Indication
Disease Entry Status REF
Chronic myelogenous leukemia Investigative [1]
Component Drugs GYKI-52466   DM3YG5P Acarbose   DMRM3AW
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL
High-throughput Screening Result Testing Cell Line: KBM-7
Zero Interaction Potency (ZIP) Score: 12.95
Bliss Independence Score: 12.95
Loewe Additivity Score: 25.43
LHighest Single Agent (HSA) Score: 25.43

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of GYKI-52466
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Terminated [2]
GYKI-52466 Interacts with 2 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Glutamate receptor AMPA 1 (GRIA1) TTVPQTF GRIA1_HUMAN Inhibitor [5]
Glutamate receptor AMPA (GRIA) TTAN6JD NOUNIPROTAC Inhibitor [5]
------------------------------------------------------------------------------------
Indication(s) of Acarbose
Disease Entry ICD 11 Status REF
Diabetic complication 5A2Y Approved [3]
Non-insulin dependent diabetes 5A11 Approved [4]
Cardiovascular disease BA00-BE2Z Phase 3 [3]
Acarbose Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Intestinal maltase-glucoamylase (MGAM) TTXWASR MGA_HUMAN Modulator [6]
------------------------------------------------------------------------------------

References

1 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4210).
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6791).
4 Acarbose FDA Label
5 New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists. Bioorg Med Chem Lett. 2006 Jan 1;16(1):167-70.
6 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.